Atossa Therapeutics, Inc. (FRA:YAG2)

Atossa Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	72	115	100	63	178	30
Market Cap Growth	-40.79%	15.00%	59.31%	-64.85%	487.14%	137.51%
Enterprise Value	27	43	15	-47	56	23
Last Close Price	0.55	0.96	0.92	0.48	1.40	0.70
PB Ratio	1.69	1.66	1.21	0.57	1.47	1.37
P/TBV Ratio	1.69	1.66	1.21	0.57	1.47	1.40
Debt / Equity Ratio	-	-	-	-	-	0.00
Quick Ratio	6.30	14.31	16.90	20.05	43.97	2.57
Current Ratio	6.77	14.99	17.61	21.23	45.18	2.73
Return on Equity (ROE)	-48.89%	-31.39%	-28.80%	-21.05%	-24.93%	-88.42%
Return on Assets (ROA)	-29.87%	-19.99%	-17.84%	-13.07%	-13.93%	-31.85%
Return on Capital (ROIC)	-33.26%	-21.25%	-18.77%	-13.52%	-15.52%	-45.20%
Return on Capital Employed (ROCE)	-66.00%	-38.60%	-34.50%	-23.50%	-14.90%	-53.80%
Earnings Yield	-35.91%	-21.47%	-27.29%	-40.29%	-10.17%	-48.03%
FCF Yield	-31.28%	-17.72%	-19.00%	-31.06%	-8.13%	-31.20%
Buyback Yield / Dilution	-2.39%	0.18%	0.43%	-8.27%	-934.13%	-33.09%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.